Garrett Motion Inc. (GTX) stock
Close on Nov 17, 2026Market cap $3.76BP/E 10.5Yield –
Earnings
Garrett Motion's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Garrett Motion's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 18, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 29, 2026before the open | $930.00M | +3.1% | $0.51 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 29, 2026before the open | $976.00M | +6.9% | $0.53 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 30, 2026before the open | $985.00M | +12.2% | $0.49 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 19, 2026before the open | $891.00M | +5.6% | $0.42 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 23, 2025before the open | $902.00M | +9.2% | $0.38 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 24, 2025before the open | $913.00M | +2.6% | $0.42 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 1, 2025before the open | $878.00M | -4.0% | $0.30 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 20, 2025before the open | $844.00M | -10.7% | $0.47 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 24, 2024before the open | $826.00M | -14.0% | $0.24 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 25, 2024before the open | $890.00M | -12.0% | $0.28 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 25, 2024before the open | $915.00M | – | $0.28 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 15, 2024before the open | $945.00M | +5.2% | $0.22 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 24, 2023before the open | $960.00M | +1.6% | $0.23 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 27, 2023before the open | $1.01B | +17.7% | -$1.88 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 4, 2023before the open | – | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 14, 2023before the open | $898.00M | +4.2% | $0.23 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 26, 2022before the open | $945.00M | +12.6% | $0.21 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 28, 2022before the open | $859.00M | – | $0.15 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 28, 2022before the open | $901.00M | – | $0.15 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 14, 2022before the open | $862.00M | – | $0.29 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 28, 2021before the open | $839.00M | – | $0.20 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 29, 2021before the open | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 29, 2021before the open | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Jul 30, 2020before the open | – | – | – | Filing |
| Q1 FY2020ended Mar 31, 2020 | Apr 7, 2020after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Garrett Motion's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net sales (GAAP)GAAP | FY2026 | $3.75B – $3.85B | $3.70B – $3.90B | Narrowed | Oct 29, 2026 |
| Net sales (GAAP)GAAP | FY2026 | $3.60B – $3.90B | $3.60B – $3.80B | Raised | Apr 30, 2026 |
| Net sales growth at constant currency (Non-GAAP)*non-GAAP | FY2026 | +2% – +6% | +1% – +7% | Narrowed | Oct 29, 2026 |
| Net sales growth at constant currency (Non-GAAP)*non-GAAP | FY2026 | -2% – +6% | -2% – +2% | Raised | Apr 30, 2026 |
| Reported net sales (% change)GAAP | FY2026 | +1% – +9% | – | New | Apr 30, 2026 |
| Adjusted EBIT (Non-GAAP)*non-GAAP | FY2026 | $570.00M – $590.00M | $560.00M – $600.00M | Narrowed | Oct 29, 2026 |
| Adjusted EBIT (Non-GAAP)*non-GAAP | FY2026 | $520.00M – $600.00M | $520.00M – $570.00M | Raised | Apr 30, 2026 |
| Full Year 2026 Outlook Adjusted EBITDAnon-GAAP | FY2026 | $696.00M – $716.00M | $688.00M – $728.00M | Narrowed | Oct 29, 2026 |
| Full Year 2026 Outlook Adjusted EBITDAnon-GAAP | FY2026 | $647.00M – $727.00M | $647.00M – $697.00M | Raised | Apr 30, 2026 |
| Adjusted free cash flow (Non-GAAP)*non-GAAP | FY2026 | $410.00M – $450.00M | $385.00M – $475.00M | Narrowed | Oct 29, 2026 |
| Adjusted free cash flow (Non-GAAP)*non-GAAP | FY2026 | $355.00M – $475.00M | $355.00M – $455.00M | Raised | Apr 30, 2026 |
| Capital expenditures | FY2026 | 2.4% | 2.4% | Reaffirmed | Oct 29, 2026 |
| Capital expenditures | FY2026 | 2.5% | – | New | Apr 30, 2026 |
| Expenditures for property, plant and equipment | FY2026 | $90.00M | – | New | Apr 30, 2026 |
| Net cash provided by operating activitiesGAAP | FY2026 | $435.00M – $525.00M | – | Raised | Jul 29, 2026 |
| Net cash provided by operating activities (GAAP)GAAP | FY2026 | $460.00M – $500.00M | – | Raised | Oct 29, 2026 |
| Net cash provided by operating activities (GAAP)GAAP | FY2026 | $407.00M – $522.00M | $407.00M – $502.00M | Raised | Apr 30, 2026 |
| Net incomeGAAP | FY2026 | $330.00M – $360.00M | – | New | Jul 29, 2026 |
| Net income (GAAP)GAAP | FY2026 | $337.00M – $352.00M | – | Lowered | Oct 29, 2026 |
| Net income (GAAP)GAAP | FY2026 | $300.00M – $360.00M | $295.00M – $335.00M | Lowered | Apr 30, 2026 |
| RD&E investment | FY2026 | 4.1% | – | New | Jul 29, 2026 |
| RD&E investment | FY2026 | 4.2% | – | New | Apr 30, 2026 |
Guidance vs results
The last range Garrett Motion gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $3.50B – $3.60B | $3.58BΣ4Q | Within range |
Guidance history
Every forecast Garrett Motion put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 29, 2026 | Capital expenditures | FY2026 | 2.4% | Reaffirmed |
| Oct 29, 2026 | Full Year 2026 Outlook Adjusted EBITDA | FY2026 | $696.00M – $716.00M | Narrowed |
| Oct 29, 2026 | Adjusted free cash flow (Non-GAAP)* | FY2026 | $410.00M – $450.00M | Narrowed |
| Oct 29, 2026 | Adjusted EBIT (Non-GAAP)* | FY2026 | $570.00M – $590.00M | Narrowed |
| Oct 29, 2026 | Net income (GAAP) | FY2026 | $337.00M – $352.00M | Lowered |
| Oct 29, 2026 | Net cash provided by operating activities (GAAP) | FY2026 | $460.00M – $500.00M | Raised |
| Oct 29, 2026 | Net sales growth at constant currency (Non-GAAP)* | FY2026 | +2% – +6% | Narrowed |
| Oct 29, 2026 | Net sales (GAAP) | FY2026 | $3.75B – $3.85B | Narrowed |
| Jul 29, 2026 | Capital expenditures | FY2026 | 2.4% | New |
| Jul 29, 2026 | Adjusted EBITDA | FY2026 | $688.00M – $728.00M | New |
| Jul 29, 2026 | Adjusted free cash flow | FY2026 | $385.00M – $475.00M | New |
| Jul 29, 2026 | Adjusted EBIT | FY2026 | $560.00M – $600.00M | New |
| Jul 29, 2026 | RD&E investment | FY2026 | 4.1% | New |
| Jul 29, 2026 | Net income | FY2026 | $330.00M – $360.00M | New |
| Jul 29, 2026 | Net cash provided by operating activities | FY2026 | $435.00M – $525.00M | Raised |
| Jul 29, 2026 | Net sales growth at constant currency | FY2026 | +1% – +7% | New |
| Jul 29, 2026 | Net sales | FY2026 | $3.70B – $3.90B | New |
| Apr 30, 2026 | Capital expenditures | FY2026 | 2.5% | New |
| Apr 30, 2026 | Expenditures for property, plant and equipment | FY2026 | $90.00M | New |
| Apr 30, 2026 | Full Year 2026 Outlook Adjusted EBITDA | FY2026 | $647.00M – $727.00M | Raised |
| Apr 30, 2026 | Adjusted free cash flow (Non-GAAP)* | FY2026 | $355.00M – $475.00M | Raised |
| Apr 30, 2026 | Adjusted EBIT (Non-GAAP)* | FY2026 | $520.00M – $600.00M | Raised |
| Apr 30, 2026 | RD&E investment | FY2026 | 4.2% | New |
| Apr 30, 2026 | Net income (GAAP) | FY2026 | $300.00M – $360.00M | Lowered |
| Apr 30, 2026 | Net cash provided by operating activities (GAAP) | FY2026 | $407.00M – $522.00M | Raised |
| Apr 30, 2026 | Reported net sales (% change) | FY2026 | +1% – +9% | New |
| Apr 30, 2026 | Net sales growth at constant currency (Non-GAAP)* | FY2026 | -2% – +6% | Raised |
| Apr 30, 2026 | Net sales (GAAP) | FY2026 | $3.60B – $3.90B | Raised |
| Feb 19, 2026 | Full Year 2026 Outlook Adjusted EBITDA (Non-GAAP) | FY2026 | $647.00M – $697.00M | New |
| Feb 19, 2026 | Adjusted free cash flow (Non-GAAP)* | FY2026 | $355.00M – $455.00M | New |
| Feb 19, 2026 | Adjusted EBIT (Non-GAAP)* | FY2026 | $520.00M – $570.00M | New |
| Feb 19, 2026 | Net income (GAAP) | FY2026 | $295.00M – $335.00M | New |
| Feb 19, 2026 | Net cash provided by operating activities (GAAP) | FY2026 | $407.00M – $502.00M | Raised |
| Feb 19, 2026 | Net sales growth at constant currency (Non-GAAP)* | FY2026 | -2% – +2% | New |
| Feb 19, 2026 | Net sales (GAAP) | FY2026 | $3.60B – $3.80B | New |
| Oct 23, 2025 | Adjusted EBITDA (Non-GAAP)* | FY2025 | $610.00M – $650.00M | Raised |
| Oct 23, 2025 | Adjusted free cash flow (Non-GAAP)* | FY2025 | $350.00M – $420.00M | Raised |
| Oct 23, 2025 | Adjusted EBIT (Non-GAAP)* | FY2025 | $490.00M – $530.00M | Raised |
| Oct 23, 2025 | Net income (GAAP) | FY2025 | $265.00M – $295.00M | Lowered |
| Oct 23, 2025 | Net cash provided by operating activities (GAAP) | FY2025 | $380.00M – $450.00M | Raised |
| Oct 23, 2025 | Net sales growth at constant currency (Non-GAAP)* | FY2025 | -1% – +2% | Raised |
| Oct 23, 2025 | Net sales (GAAP) | FY2025 | $3.50B – $3.60B | Raised |
| Jul 24, 2025 | Capital expenditures | FY2025 | 2.5% | New |
| Jul 24, 2025 | Adjusted EBITDA (Non-GAAP)* | FY2025 | $590.00M – $650.00M | New |
| Jul 24, 2025 | Adjusted free cash flow (Non-GAAP)* | FY2025 | $330.00M – $410.00M | New |
| Jul 24, 2025 | Adjusted EBIT (Non-GAAP)* | FY2025 | $470.00M – $530.00M | New |
| Jul 24, 2025 | Net income (GAAP) | FY2025 | $233.00M – $278.00M | New |
| Jul 24, 2025 | Net cash provided by operating activities (GAAP) | FY2025 | $370.00M – $450.00M | Raised |
| Jul 24, 2025 | Net sales growth at constant currency (Non-GAAP)* | FY2025 | -3% – +2% | New |
| Jul 24, 2025 | Net sales (GAAP) | FY2025 | $3.40B – $3.60B | New |
| May 1, 2025 | Capital expenditures | FY2025 | 2.8% | Reaffirmed |
| May 1, 2025 | Adjusted EBITDA (Non-GAAP)* | FY2025 | $545.00M – $605.00M | Reaffirmed |
| May 1, 2025 | Adjusted free cash flow (Non-GAAP)* | FY2025 | $300.00M – $390.00M | Reaffirmed |
| May 1, 2025 | Adjusted EBIT (Non-GAAP)* | FY2025 | $427.00M – $487.00M | Reaffirmed |
| May 1, 2025 | RD&E investment | FY2025 | 4.6% | Reaffirmed |
| May 1, 2025 | Net income (GAAP) | FY2025 | $209.00M – $254.00M | Lowered |
| May 1, 2025 | Net cash provided by operating activities (GAAP) | FY2025 | $357.00M – $447.00M | Raised |
| May 1, 2025 | Net sales growth at constant currency (Non-GAAP)* | FY2025 | -3% – +2% | Reaffirmed |
| May 1, 2025 | Net sales (GAAP) | FY2025 | $3.30B – $3.50B | Reaffirmed |
| Feb 20, 2025 | Capital expenditures at 2.8% of sales | FY2025 | 2.8% | New |
| Feb 20, 2025 | Adjusted EBITDA (Non-GAAP) | FY2025 | $545.00M – $605.00M | New |
| Feb 20, 2025 | Adjusted free cash flow (Non-GAAP) | FY2025 | $300.00M – $390.00M | New |
| Feb 20, 2025 | Adjusted EBIT (Non-GAAP) | FY2025 | $427.00M – $487.00M | New |
| Feb 20, 2025 | RD&E investment at 4.6% of sales in 2025 | FY2025 | 4.6% | New |
| Feb 20, 2025 | Net income (GAAP) | FY2025 | $209.00M – $254.00M | New |
| Feb 20, 2025 | Net cash provided by operating activities (GAAP) | FY2025 | $357.00M – $447.00M | Raised |
| Feb 20, 2025 | Net sales growth at constant currency (Non-GAAP) | FY2025 | -3% – +2% | New |
| Feb 20, 2025 | Net sales (GAAP) | FY2025 | $3.30B – $3.50B | New |
| Oct 24, 2024 | Capital expenditures | FY2024 | 2.5% | Raised |
| Oct 24, 2024 | Adjusted EBITDA (Non-GAAP)* | FY2024 | $585.00M – $605.00M | Narrowed |
| Oct 24, 2024 | Adjusted free cash flow (Non-GAAP)* | FY2024 | $300.00M – $350.00M | Lowered |
| Oct 24, 2024 | RD&E | FY2024 | 4.7% | Raised |
| Oct 24, 2024 | Net income (GAAP) | FY2024 | $240.00M – $255.00M | Lowered |
| Oct 24, 2024 | Net cash provided by operating activities (GAAP) | FY2024 | $348.00M – $398.00M | Raised |
| Oct 24, 2024 | Net sales growth at constant currency (Non-GAAP)* | FY2024 | -12% – -10% | Lowered |
| Oct 24, 2024 | Net sales (GAAP) | FY2024 | $3.40B – $3.50B | Lowered |
| Jul 25, 2024 | Capital expenditures | FY2024 | 2.4% | Raised |
| Jul 25, 2024 | Adjusted EBITDA (Non-GAAP) | FY2024 | $583.00M – $633.00M | Lowered |
| Jul 25, 2024 | Adjusted free cash flow (Non-GAAP) | FY2024 | $300.00M – $400.00M | Lowered |
| Jul 25, 2024 | RD&E | FY2024 | 4.4% | Lowered |
| Jul 25, 2024 | Net income (GAAP) | FY2024 | $245.00M – $285.00M | Lowered |
| Jul 25, 2024 | Net cash provided by operating activities (GAAP) | FY2024 | $355.00M – $455.00M | Raised |
| Jul 25, 2024 | Net sales growth at constant currency (Non-GAAP) | FY2024 | -9% – -5% | Lowered |
| Jul 25, 2024 | Net sales (GAAP) | FY2024 | $3.50B – $3.65B | Lowered |
| Apr 25, 2024 | Adjusted EBITDA (Non-GAAP)* | FY2024 | $590.00M – $650.00M | Reaffirmed |
| Apr 25, 2024 | Adjusted free cash flow (Non-GAAP)* | FY2024 | $325.00M – $425.00M | Reaffirmed |
| Apr 25, 2024 | Net income (GAAP) | FY2024 | $230.00M – $275.00M | Lowered |
| Apr 25, 2024 | Net cash provided by operating activities (GAAP) | FY2024 | $370.00M – $470.00M | Raised |
| Apr 25, 2024 | Net sales growth at constant currency (Non-GAAP)* | FY2024 | -2% – +2% | Reaffirmed |
| Apr 25, 2024 | Net sales (GAAP) | FY2024 | $3.80B – $3.95B | Reaffirmed |
| Feb 15, 2024 | Capital expenditures | FY2024 | 2.2% | New |
| Feb 15, 2024 | Adjusted EBITDA (Non-GAAP)* | FY2024 | $590.00M – $650.00M | New |
| Feb 15, 2024 | Adjusted free cash flow (Non-GAAP)* | FY2024 | $325.00M – $425.00M | New |
| Feb 15, 2024 | Net income (GAAP) | FY2024 | $230.00M – $275.00M | New |
| Feb 15, 2024 | RD&E investment | FY2024 | 4.5% | New |
| Feb 15, 2024 | Net cash provided by operating activities (GAAP) | FY2024 | $370.00M – $470.00M | Raised |
| Feb 15, 2024 | Net sales growth at constant currency (Non-GAAP)* | FY2024 | -2% – +2% | New |
| Feb 15, 2024 | Net sales (GAAP) | FY2024 | $3.80B – $3.95B | New |
| Oct 24, 2023 | Adjusted EBITDA (Non-GAAP)* | FY2023 | $615.00M – $645.00M | Lowered |
| Oct 24, 2023 | Adjusted free cash flow (Non-GAAP)* | FY2023 | $350.00M – $400.00M | Narrowed |
| Oct 24, 2023 | Net income (GAAP) | FY2023 | $252.00M – $272.00M | Lowered |
| Oct 24, 2023 | Net cash provided by operating activities (GAAP) | FY2023 | $413.00M – $463.00M | Raised |
| Oct 24, 2023 | Net sales growth at constant currency (Non-GAAP)* | FY2023 | +7% – +9% | Narrowed |
| Oct 24, 2023 | Net sales (GAAP) | FY2023 | $3.83B – $3.90B | Lowered |
| Jul 27, 2023 | Capital expenditures | FY2023 | 2.3% | New |
| Jul 27, 2023 | Adjusted EBITDA (Non-GAAP)* | FY2023 | $620.00M – $670.00M | Raised |
| Jul 27, 2023 | Adjusted free cash flow (Non-GAAP)* | FY2023 | $340.00M – $440.00M | Raised |
| Jul 27, 2023 | Net cash provided by operating activities (GAAP) | FY2023 | $410.00M – $510.00M | Raised |
| Jul 27, 2023 | R&D investment | FY2023 | 4.3% | New |
| Jul 27, 2023 | Net income (GAAP) | FY2023 | $255.00M – $290.00M | Lowered |
| Jul 27, 2023 | Net sales growth at constant currency (Non-GAAP)* | FY2023 | +6% – +11% | Raised |
| Jul 27, 2023 | Net sales (GAAP) | FY2023 | $3.84B – $4.03B | Raised |
| Apr 4, 2023 | Adjusted EBITDA (Non-GAAP)* | FY2023 | $555.00M – $615.00M | Reaffirmed |
| Apr 4, 2023 | Adjusted free cash flow (Non-GAAP)* | FY2023 | $300.00M – $400.00M | Reaffirmed |
| Apr 4, 2023 | Net income (GAAP) | FY2023 | $255.00M – $300.00M | Lowered |
| Apr 4, 2023 | Net cash provided by operating activities (GAAP) | FY2023 | $390.00M – $490.00M | Raised |
| Apr 4, 2023 | Net sales (GAAP) | FY2023 | $3.55B – $3.85B | Reaffirmed |
| Apr 4, 2023 | Net sales growth at constant currency (Non-GAAP)* | FY2023 | +1% – +6% | Reaffirmed |
| Feb 14, 2023 | Adjusted EBITDA (Non-GAAP)* | FY2023 | $555.00M – $615.00M | New |
| Feb 14, 2023 | Adjusted free cash flow (Non-GAAP)* | FY2023 | $300.00M – $400.00M | New |
| Feb 14, 2023 | Net income (GAAP) | FY2023 | $255.00M – $300.00M | New |
| Feb 14, 2023 | Net cash provided by operating activities (GAAP) | FY2023 | $390.00M – $490.00M | Raised |
| Feb 14, 2023 | Net sales growth at constant currency (Non-GAAP)* | FY2023 | +1% – +6% | New |
| Feb 14, 2023 | Net sales (GAAP) | FY2023 | $3.55B – $3.85B | New |
| Oct 26, 2022 | Adjusted EBITDA (Non-GAAP)* | FY2022 | $545.00M – $575.00M | Narrowed |
| Oct 26, 2022 | Adjusted free cash flow (Non-GAAP)* | FY2022 | $310.00M – $370.00M | Lowered |
| Oct 26, 2022 | Net income (GAAP) | FY2022 | $325.00M – $345.00M | Lowered |
| Oct 26, 2022 | Net cash provided by operating activities (GAAP) | FY2022 | $380.00M – $440.00M | Raised |
| Oct 26, 2022 | Net sales growth at constant currency (Non-GAAP)* | FY2022 | +7% – +9% | Narrowed |
| Oct 26, 2022 | Net sales (GAAP) | FY2022 | $3.57B – $3.67B | Narrowed |
| Jul 28, 2022 | Adjusted EBITDA (Non-GAAP)* | FY2022 | $530.00M – $590.00M | Reaffirmed |
| Jul 28, 2022 | Adjusted free cash flow (Non-GAAP)* | FY2022 | $330.00M – $430.00M | Reaffirmed |
| Jul 28, 2022 | Net income (GAAP) | FY2022 | $290.00M – $335.00M | Lowered |
| Jul 28, 2022 | Net cash provided by operating activities (GAAP) | FY2022 | $405.00M – $505.00M | Raised |
| Jul 28, 2022 | Net sales growth at constant currency (Non-GAAP)* | FY2022 | +5% – +10% | Raised |
| Jul 28, 2022 | Net sales (GAAP) | FY2022 | $3.50B – $3.70B | Reaffirmed |
| Apr 28, 2022 | Adjusted EBITDA (Non-GAAP)* | FY2022 | $530.00M – $590.00M | Lowered |
| Apr 28, 2022 | Adjusted free cash flow (Non-GAAP)* | FY2022 | $330.00M – $430.00M | Lowered |
| Apr 28, 2022 | Net income (GAAP) | FY2022 | $250.00M – $295.00M | Lowered |
| Apr 28, 2022 | Net cash provided by operating activities (GAAP) | FY2022 | $405.00M – $505.00M | Raised |
| Apr 28, 2022 | Net sales growth at constant currency (Non-GAAP)* | FY2022 | +1% – +6% | Lowered |
| Apr 28, 2022 | Net sales (GAAP) | FY2022 | $3.50B – $3.70B | Lowered |
| Feb 14, 2022 | capital expenditures | FY2022 | 2.4% | New |
| Feb 14, 2022 | Adjusted EBITDA | FY2022 | $590.00M – $650.00M | New |
| Feb 14, 2022 | Adjusted free cash flow | FY2022 | $400.00M – $500.00M | New |
| Feb 14, 2022 | R&D expenses | FY2022 | 4.6% | New |
| Feb 14, 2022 | Net income | FY2022 | $295.00M – $340.00M | New |
| Feb 14, 2022 | Net cash provided by operating activities | FY2022 | $485.00M – $585.00M | Raised |
| Feb 14, 2022 | Net sales growth at constant currency | FY2022 | +4% – +13% | New |
| Feb 14, 2022 | Net sales | FY2022 | $3.70B – $4.00B | New |
| Oct 28, 2021 | Adjusted EBITDA (Non-GAAP) | FY2021 | $590.00M – $620.00M | New |
| Oct 28, 2021 | Adjusted free cash flow (Non-GAAP) | FY2021 | $280.00M – $340.00M | New |
| Oct 28, 2021 | Net income (GAAP) | FY2021 | $405.00M – $435.00M | New |
| Oct 28, 2021 | Net cash used for operating activities (GAAP) | FY2021 | -$355.00M – -$295.00M | Lowered |
| Oct 28, 2021 | Net sales growth at constant currency (Non-GAAP) | FY2021 | +14% – +17% | New |
| Oct 28, 2021 | Net sales (GAAP) | FY2021 | $3.60B – $3.70B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Garrett Motion filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- News
- Results
- Results
- News
See a number that looks wrong?